An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

This robust growth is primarily driven by increasing demand for biologics, advancements in manufacturing technologies, and ...

As Modern Healthcare reports, CMS has relaxed supervision requirements for physical and occupational therapist assistants from “direct” to “general.” The change could help health systems manage ...

As the COVID-19 pandemic clearly demonstrated, health is an integral part of Europe’s security. That principle underpinned a ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Schrödinger, Inc. is a company at the forefront of molecular discovery, utilizing its advanced computational platform for drug development and materials design, primarily serving the biotechnology and ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Case No. 27 pertains to the finding of "reasonable expectation of success" in the inventiveness assessment of an invention ...

Schrödinger shares rise as they announce a research partnership and licensing agreement with Novartis AG. Schrödinger will ...